Curis
CRIS
#11081
Rank
A$0.96 M
Marketcap
A$0.49
Share price
-17.89%
Change (1 day)
-80.39%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -A$9.9 Million

According to Curis's latest financial reports the company's current earnings are A$7.06 Million. In 2025 the company made an earning of -A$7.69 Million, an increase over its 2024 earnings that were of -A$60.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$9.9 Million28.86%
2025 -A$7.69 Million-87.38%
2024 -A$60.89 Million-5.77%
2023 -A$64.62 Million-13.1%
2022 -A$74.36 Million27.52%
2021 -A$58.31 Million65.09%
2020 -A$35.32 Million-9.1%
2019 -A$38.86 Million-4.73%
2018 -A$40.79 Million-41.95%
2017 -A$70.25 Million-14.37%
2016 -A$82.04 Million3.55%
2015 -A$79.22 Million271.52%
2014 -A$21.33 Million76.64%
2013 -A$12.08 Million
2011 -A$10.26 Million27.76%
2010 -A$8.03 Million-43.87%
2009 -A$14.3 Million-23.44%
2008 -A$18.68 Million56.66%
2007 -A$11.93 Million-16.71%
2006 -A$14.32 Million-36.92%
2005 -A$22.69 Million156.25%
2004 -A$8.86 Million-37.24%
2003 -A$14.11 Million-93.34%
2002 -A$0.22 Billion86.79%
2001 -A$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$15.07 B-156,794.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.66 B-142,088.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-A$88.09 Million 815.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$1.42 B-14,942.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.44 Billion 4,472.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-A$31.6 Million 228.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$84.12 M-974.39%๐Ÿ‡บ๐Ÿ‡ธ USA